Accelerate Your Path to Clinical-Grade Cell Therapies
Advance your cell therapy programs with R&D Systems™-your trusted source for high‑quality reagents, assays, and workflow solutions that scale from bench to GMP manufacturing. Whether you’re engineering T cells for oncology, expanding NK cells for allogeneic applications, or optimizing stem cell culture for regenerative medicine, we deliver lot‑to‑lot consistency, regulatory‑ready documentation, and end‑to‑end technical support to help you move faster with confidence.
- Industry‑leading selection of RUO to GMP-grade cytokines, growth factors, antibodies, and immunoassays
- Robust QC and traceability for IND-filing and regulatory approval
- Flexible solutions for closed, automated and scalable manufacturing processes
- Experience supporting customer transition from translational to clinical workflows
Immune Cell Therapy
Streamline Your Path to Clinic
Drive robust activation, expansion, and functional performance of your immune cell therapies with R&D Systems. From culture to analysis, our flexible animal-free GMP and closed‑system workflow solutions support reliable non-viral genome engineering, cell expansion and phenotype maintenance, while reducing risk and streamlining scale‑up, cGMP manufacturing, product characterization and regulatory approval.
Power your CAR‑T, TCR‑T, and NK cell programs from preclinical research through clinical production with quality reagents in process‑ready formats and automated analytical platforms.
Regenerative Medicine
Improve Your Culture Consistency
Establish reproducible and scalable processes for your stem cell-based therapies with R&D Systems. From first passage to final characterization, our animal-free GMP reagents, AI‑modified proteins, and new synthetic hydrogel support consistent expansion, lineage‑specific differentiation, and downstream manufacturing by minimizing variability and improving lot‑to‑lot reproducibility.
Partner with us from early-stage development to clinical scale manufacturing to accelerate your stem cell-based therapeutic programs.
Cell Separation for Cell Therapy
Bead- and column-based cell selection technologies for high-purity isolation of immune and stem cell lineages.
Cell Culture for Cell Therapy
RUO to GMP-grade cytokines and growth factors, small molecules, media and supplements, extracellular matrices, differentiation kits and analysis tools.
Non-viral Genome Editing for Cell Therapy
Derisk your cell therapy with TcBuster non-viral transposon-based genome engineering technology. Achieve stable integration at low cost and rapid turnaround time.
Product Release Testing for Cell Manufacturing
Characterize your cell populations at every stage along the cell therapy workflow using flow cytometry antibodies and sensitive immunoassays. We offer immunoassay options that are tailored to research and clinical level cell characterization.
Monitoring Efficacy and Toxicity
Verify that your cell therapy treatment is effective and safe. We offer premium reagents and assays to monitor outcomes including cell engraftment, host immune cell infiltration, disease status, and the cytokine storm.
Custom Solutions for Cell Therapy
Efficient workflows often require customized solutions. Leverage the scientific expertise of R&D Systems scientists to guide you through your manufacturing process during the development, scale up, and manufacturing of your cell or gene therapy.
R&D Systems believes in the power of partnerships. We have joined with Fresenius Kabi and Wilson Wolf to bring you ScaleReady™, lowering the barriers to entry into the immune cell therapy space for all sizes and stages of manufacturing programs. ScaleReady brings cell and gene therapies to life by offering a significant reduction of complexity and cost while consistently providing superior repeatability and cell quality.
The ScaleReady product portfolio supports scalable immune cell therapy solutions, delivering true platform, process, and product continuity for your immune cell programs. When paired with functionally-closed-system automated cell processing systems, R&D Systems reagents and the G-Rex® Bioreactor enable high throughput parallel processing of cell therapies within a small footprint.